We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$175M
2
WELL icon
Welltower
WELL
+$148M
3
CUZ icon
Cousins Properties
CUZ
+$121M
4
DLR icon
Digital Realty Trust
DLR
+$103M
5
VICI icon
VICI Properties
VICI
+$96.6M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
1151
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$6K ﹤0.01%
356
+188
+112% +$2.05K
ATRA icon
1152
Atara Biotherapeutics
ATRA
$70.4M
$5K ﹤0.01%
12
+6
+100% +$2.15K
CDXS icon
1153
Codexis
CDXS
$136M
$5K ﹤0.01%
221
+110
+99% +$2.6K
GBIO
1154
DELISTED
Generation Bio
GBIO
$5K ﹤0.01%
19
+8
+73% +$1.92K
MDGL icon
1155
Madrigal Pharmaceuticals
MDGL
$12.4B
$5K ﹤0.01%
57
+28
+97% +$2.42K
NRIX icon
1156
Nurix Therapeutics
NRIX
$2.51B
$5K ﹤0.01%
152
+79
+108% +$2.44K
PCVX icon
1157
Vaxcyte
PCVX
$7.88B
$5K ﹤0.01%
179
+83
+86% +$2.01K
QURE icon
1158
uniQure
QURE
$2.52B
$5K ﹤0.01%
158
+74
+88% +$2.26K
REPL icon
1159
Replimune Group
REPL
$449M
$5K ﹤0.01%
160
+74
+86% +$2.4K
SUPN icon
1160
Supernus Pharmaceuticals
SUPN
$2.77B
$5K ﹤0.01%
182
+83
+84% +$2.23K
TVTX icon
1161
Travere Therapeutics
TVTX
$5.2B
$5K ﹤0.01%
208
+94
+82% +$1.73K
RUBY
1162
DELISTED
Rubius Therapeutics, Inc
RUBY
$5K ﹤0.01%
307
+129
+72% +$2.81K
GBT
1163
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
214
+98
+84% +$2.88K
DRNA
1164
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5K ﹤0.01%
266
+125
+89% +$3.45K
KDMN
1165
DELISTED
Kadmon Holdings, Inc.
KDMN
$5K ﹤0.01%
590
+267
+83% +$1.52K
ARQT icon
1166
Arcutis Biotherapeutics
ARQT
$3.55B
$4K ﹤0.01%
172
+73
+74% +$1.67K
AXSM icon
1167
Axsome Therapeutics
AXSM
$12.1B
$4K ﹤0.01%
129
+59
+84% +$2.3K
BLUE
1168
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
18
+8
+80% +$2.29K
CHRS icon
1169
Coherus Oncology
CHRS
$222M
$4K ﹤0.01%
262
+127
+94% +$1.86K
ENTA icon
1170
Enanta Pharmaceuticals
ENTA
$367M
$4K ﹤0.01%
69
+31
+82% +$1.53K
FULC icon
1171
Fulcrum Therapeutics
FULC
$248M
$4K ﹤0.01%
138
+86
+165% +$1.63K
KRYS icon
1172
Krystal Biotech
KRYS
$10.7B
$4K ﹤0.01%
76
+33
+77% +$1.95K
KURA icon
1173
Kura Oncology
KURA
$826M
$4K ﹤0.01%
227
+96
+73% +$1.81K
MGNX icon
1174
MacroGenics
MGNX
$245M
$4K ﹤0.01%
209
+103
+97% +$2.48K
MNKD icon
1175
MannKind Corp
MNKD
$1.21B
$4K ﹤0.01%
855
-99,582
-99% -$449K
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.